|
|
ix | |
Woodhead Publishing Series in Biomaterials |
|
xi | |
|
Part One Introduction and fundamentals |
|
|
1 | (84) |
|
1 Introduction to biomedical polymers and biocompatibility |
|
|
3 | (30) |
|
|
|
|
3 | (1) |
|
1.2 Natural or biological polymers |
|
|
4 | (14) |
|
1.3 Advantages and disadvantages of natural polymers |
|
|
18 | (9) |
|
1.4 Biosynthetic polymers |
|
|
27 | (1) |
|
|
28 | (5) |
|
|
28 | (5) |
|
2 Nondegradable synthetic polymers for medical devices and implants |
|
|
33 | (30) |
|
|
|
|
33 | (1) |
|
2.2 Ultra-high molecular weight poly(ethylene) (UHMWPE) |
|
|
34 | (6) |
|
|
40 | (2) |
|
2.4 Poly(methyl methacrylate) (PMMA) |
|
|
42 | (2) |
|
|
44 | (5) |
|
2.6 Poly(dimethyl siloxane) (PDMS) |
|
|
49 | (4) |
|
2.7 Polyether ether ketone (PEEK) |
|
|
53 | (2) |
|
|
55 | (8) |
|
|
56 | (7) |
|
3 Biodegradable and bioerodible polymers for medical applications |
|
|
63 | (22) |
|
|
|
|
63 | (1) |
|
3.2 Concepts and terminology |
|
|
63 | (8) |
|
3.3 Motivating factors for using polymer--drug conjugates |
|
|
71 | (4) |
|
3.4 Current and future trends |
|
|
75 | (10) |
|
|
78 | (1) |
|
|
78 | (7) |
|
Part Two Coatings and surface modifications |
|
|
85 | (86) |
|
4 Bio-inspired antimicrobial polymers |
|
|
87 | (42) |
|
|
|
|
|
|
|
|
87 | (2) |
|
4.2 Naturally occurring AMPs |
|
|
89 | (8) |
|
4.3 Synthetic polymer mimics of AMPs |
|
|
97 | (13) |
|
4.4 Chitosan -- a natural antimicrobial polysaccharide |
|
|
110 | (4) |
|
4.5 Neutral polymer brush layers for reducing bacterial attachment |
|
|
114 | (15) |
|
|
119 | (10) |
|
5 Plasma-based surface modification for the control of biointerfacial interactions |
|
|
129 | (16) |
|
|
|
129 | (3) |
|
5.2 Plasma treatment of material surfaces |
|
|
132 | (2) |
|
5.3 Plasma polymer-based coatings |
|
|
134 | (2) |
|
5.4 Plasma polymer-based interlayers |
|
|
136 | (1) |
|
5.5 Plasma polymer-based patterning |
|
|
137 | (3) |
|
5.6 Functional plasma polymers |
|
|
140 | (1) |
|
5.7 Antimicrobial plasma polymer coatings |
|
|
141 | (1) |
|
|
141 | (1) |
|
5.9 Sources of further information |
|
|
142 | (3) |
|
|
142 | (3) |
|
6 Stent coatings for blood compatibility |
|
|
145 | (26) |
|
|
|
145 | (1) |
|
|
145 | (2) |
|
|
147 | (6) |
|
6.4 Drug-eluting stent coatings |
|
|
153 | (7) |
|
|
160 | (11) |
|
|
160 | (1) |
|
|
161 | (10) |
|
Part Three Biosynthetic hydrogels |
|
|
171 | (70) |
|
7 Degradable hydrogel systems for biomedical applications |
|
|
173 | (16) |
|
|
|
173 | (1) |
|
|
173 | (2) |
|
7.3 Desired hydrogel properties |
|
|
175 | (1) |
|
7.4 Degradable hydrogel systems |
|
|
175 | (9) |
|
7.5 Where to? -- degradable hydrogels |
|
|
184 | (5) |
|
|
185 | (4) |
|
8 Angiogenesis in hydrogel biomaterials |
|
|
189 | (16) |
|
|
|
|
|
|
|
189 | (1) |
|
8.2 Biology of angiogenesis |
|
|
189 | (1) |
|
8.3 Protein hydrogels to support angiogenic activity |
|
|
190 | (1) |
|
8.4 Synthetic hydrogels to support angiogenic activity |
|
|
191 | (5) |
|
8.5 In vitro culture of vascular networks |
|
|
196 | (2) |
|
8.6 Inducing angiogenesis in host tissue |
|
|
198 | (1) |
|
|
199 | (6) |
|
|
199 | (6) |
|
9 Engineering biosynthetic cell encapsulation systems |
|
|
205 | (36) |
|
|
|
|
205 | (3) |
|
|
208 | (8) |
|
|
216 | (5) |
|
9.4 Biosynthetic polymers |
|
|
221 | (8) |
|
|
229 | (12) |
|
|
229 | (12) |
|
Part Four Conjugated conducting polymers |
|
|
241 | (90) |
|
10 Conducting polymers and their biomedical applications |
|
|
243 | (34) |
|
|
|
|
243 | (1) |
|
10.2 Conducting mechanism |
|
|
244 | (1) |
|
10.3 Electrochemical polymerisation of conducting polymers |
|
|
245 | (6) |
|
10.4 Applications of conducting polymers in biomedical fields |
|
|
251 | (20) |
|
|
271 | (6) |
|
|
271 | (6) |
|
11 Biosynthetic conductive polymer composites for tissue-engineering biomedical devices |
|
|
277 | (22) |
|
|
|
|
277 | (1) |
|
11.2 Conductive polymer composites |
|
|
278 | (8) |
|
11.3 Biological components in CP composites |
|
|
286 | (4) |
|
11.4 In vivo application of CP composites |
|
|
290 | (3) |
|
11.5 Summary and future directions |
|
|
293 | (6) |
|
|
294 | (5) |
|
12 Degradable conjugated conducting polymers and nerve guidance |
|
|
299 | (32) |
|
|
|
299 | (1) |
|
12.2 Material challenges in neural engineering |
|
|
300 | (1) |
|
12.3 Processing of conducting polymers for the generation of 3D scaffolds |
|
|
300 | (8) |
|
12.4 Biodegradable conducting polymers |
|
|
308 | (5) |
|
12.5 Biomolecular and topographical guidance |
|
|
313 | (7) |
|
12.6 Biological performance of CPs for neural regeneration |
|
|
320 | (1) |
|
12.7 Future trends and remaining challenges |
|
|
321 | (2) |
|
12.8 Sources for further information |
|
|
323 | (8) |
|
|
324 | (1) |
|
|
325 | (6) |
Index |
|
331 | |